These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3268925)
21. Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine. Valensin PE; Rossolini GM; Cusi MG; Zanchi A; Cellesi C; Rossolini A Vaccine; 1987 Dec; 5(4):289-94. PubMed ID: 3433917 [TBL] [Abstract][Full Text] [Related]
22. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment]. Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955 [No Abstract] [Full Text] [Related]
23. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains]. Zou J; Senecal J; Morvan A; Roussey A Ann Pediatr (Paris); 1976 Feb; 23(2):111-8. PubMed ID: 16104238 [No Abstract] [Full Text] [Related]
24. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district]. Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992 [No Abstract] [Full Text] [Related]
25. Success and failure of a rubella immunization programme. Swartz TA; Porath EB; Hornstein L Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682 [TBL] [Abstract][Full Text] [Related]
26. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus]. Neumann-Haefelin D; Neumann-Haefelin Ch; Petersen EE; Luthardt Th; Hass R Dtsch Med Wochenschr; 1975 Jan; 100(5):177-81. PubMed ID: 1112230 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562 [TBL] [Abstract][Full Text] [Related]
28. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
29. The immunoglobulin response to reimmunization with rubella vaccine. Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092 [TBL] [Abstract][Full Text] [Related]
30. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777 [TBL] [Abstract][Full Text] [Related]
31. [Immune status of a school-population sample 5 years after antirubella vaccination]. Quaglio P; Dattoli A; Mantovani G G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256 [TBL] [Abstract][Full Text] [Related]
32. [Immune status against measles and rubella among 4 Chilean groups of different ages]. Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723 [TBL] [Abstract][Full Text] [Related]
33. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. King SM; Saunders EF; Petric M; Gold R Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367 [TBL] [Abstract][Full Text] [Related]
34. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women. Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431 [TBL] [Abstract][Full Text] [Related]
35. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines]. Imbs D; Kańtoch M; Rudnicka H; Niedźwiedzka-Adamaszek E; Pychyńska A; Zegadło W; Stempień R; Słowińska I; Kretkowska A Przegl Epidemiol; 1987; 41(2):141-8. PubMed ID: 3423282 [No Abstract] [Full Text] [Related]
36. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Just M; Berger R; Glück R; Wegmann A Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399 [TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764 [TBL] [Abstract][Full Text] [Related]
38. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743 [TBL] [Abstract][Full Text] [Related]
39. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. André FE; Peetermans J Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770 [TBL] [Abstract][Full Text] [Related]
40. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)]. Hoppe G Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]